Johnson & Johnson Treasury Stock, Shares, Acquired
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Johnson & Johnson treasury stock, shares, acquired for fiscal 2016 was 52.47M shares, a 24.72% decline from fiscal 2014.
- Johnson & Johnson treasury stock, shares, acquired for fiscal 2014 was 69.71M shares, a 986.46% increase from fiscal 2013.
- Johnson & Johnson treasury stock, shares, acquired for fiscal 2013 was 6.42M shares, a 96.87% decline from fiscal 2012.
- Johnson & Johnson treasury stock, shares, acquired for fiscal 2012 was 204.78M shares, a 415.30% increase from fiscal 2012.
| Period end | Treasury Stock, Shares, Acquired 3 month | Treasury Stock, Shares, Acquired 12 month |
|---|---|---|
| 2016-01-03 | 52.47M shares 10-K · filed 2016-02-24 | |
| 2014-12-28 | 69.71M shares 10-K · filed 2016-02-24 | |
| 2013-12-29 | 6.42M shares 10-K · filed 2016-02-24 | |
| 2012-12-30 | 204.78M shares 10-K · filed 2015-02-24 | |
| 2012-01-01 | 39.74M shares 10-K · filed 2014-02-21 | |
| 2011-01-02 | 45.09M shares 10-K · filed 2013-02-22 | |
| 2010-01-03 | 37.11M shares 10-K · filed 2012-02-23 | |
| 2008-12-28 | 100.97M shares 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |